2026-07421NoticeWallet

FDA Seeks Comments on Prescription Drug Import Data Collection

Published Date: 4/16/2026

Notice

Summary

The FDA wants your thoughts on how they collect info about importing prescription drugs. This affects drug companies and anyone involved in bringing meds into the U.S. You’ve got until June 15, 2026, to share your comments—no cost to join, just your voice! The goal? Make sure the rules are clear and easy to follow.

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

Recordkeeping Burden for Importation Sponsors

If you are a Section 804 Importation Program (SIP) Sponsor, an importer (pharmacist or wholesale distributor), or a drug manufacturer, FDA estimates the paperwork burden at 100 total annual records and 6,040 hours per year. Specifically, Subpart B is estimated at 60 records at 72 hours each (4,320 hours) and Subpart C at 40 records at 43 hours each (1,720 hours).

Section 804 Aims to Lower Drug Costs

The purpose of section 804 of the Federal Food, Drug, and Cosmetic Act is to reduce the cost of covered prescription products to American consumers without imposing additional risks to public health and safety. The regulations in 21 CFR part 251 set procedures for SIP Sponsors to submit plans for time-limited programs to begin importation of drugs from Canada and establish criteria for FDA review and authorization.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Comments Due
4/16/2026
6/15/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register